These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26664138)

  • 1. Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer.
    Lin R; Yi S; Gong L; Liu W; Wang P; Liu N; Zhao L; Wang P
    Onco Targets Ther; 2015; 8():3549-59. PubMed ID: 26664138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
    Oncotarget; 2016 Nov; 7(44):71341-71352. PubMed ID: 27533085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halofuginone inhibits the establishment and progression of melanoma bone metastases.
    Juárez P; Mohammad KS; Yin JJ; Fournier PG; McKenna RC; Davis HW; Peng XH; Niewolna M; Javelaud D; Chirgwin JM; Mauviel A; Guise TA
    Cancer Res; 2012 Dec; 72(23):6247-56. PubMed ID: 23002206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
    Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis.
    Juárez P; Fournier PGJ; Mohammad KS; McKenna RC; Davis HW; Peng XH; Niewolna M; Mauviel A; Chirgwin JM; Guise TA
    Oncotarget; 2017 Oct; 8(49):86447-86462. PubMed ID: 29156807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
    McGaha TL; Phelps RG; Spiera H; Bona C
    J Invest Dermatol; 2002 Mar; 118(3):461-70. PubMed ID: 11874485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
    Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt DP; Libermann TA; Pines M
    Cell Tissue Res; 2007 Apr; 328(1):153-66. PubMed ID: 17180598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
    Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
    J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
    Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
    Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
    McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
    Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
    Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
    Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
    Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation.
    Rube CE; Uthe D; Schmid KW; Richter KD; Wessel J; Schuck A; Willich N; Rube C
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1033-42. PubMed ID: 10863076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis.
    Yavas G; Calik M; Calik G; Yavas C; Ata O; Esme H
    Med Hypotheses; 2013 Apr; 80(4):357-9. PubMed ID: 23352286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
    Hagan M; Yacoub A; Dent P
    Clin Cancer Res; 2004 Sep; 10(17):5724-31. PubMed ID: 15355899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of prostate cancer xenografts by halofuginone.
    Gavish Z; Pinthus JH; Barak V; Ramon J; Nagler A; Eshhar Z; Pines M
    Prostate; 2002 May; 51(2):73-83. PubMed ID: 11948962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
    Zhuang X; Qiao T; Xu G; Yuan S; Zhang Q; Chen X
    Oncol Rep; 2016 Oct; 36(4):2200-6. PubMed ID: 27498922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.